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Abstract
Periodontitis is a very common oral inflammatory disease that results in the destruction of
supporting connective and osseous tissues of the teeth. Although the exact etiology is still
unclear, Gram-negative bacteria, especially Porphyromonas gingivalis in subgingival pock-
ets are thought to be one of the major etiologic agents of periodontitis. Endothelin (ET) is a
family of three 21-amino acid peptides, ET-1, -2, and -3, that activate G protein-coupled
receptors, ETA and ETB. Endothelin is involved in the occurrence and progression of various
inflammatory diseases. Previous reports have shown that ET-1 and its receptors, ETA and
ETB are expressed in the periodontal tissues and, that ET-1 levels in gingival crevicular fluid
are increased in periodontitis patients. Moreover, P. gingivalis infection has been shown to
induce the production of ET-1 along with other inflammatory cytokines. Despite these stud-
ies, however, the functional significance of endothelin in periodontitis is still largely unknown.
In this study, we explored the cellular and molecular mechanisms of ET-1 action in periodon-
titis using human gingival epithelial cells (HGECs). ET-1 and ETA, but not ETB, were abun-
dantly expressed in HGECs. Stimulation of HGECs with P. gingivalis or P. gingivalis
lipopolysaccharide increased the expression of ET-1 and ETA suggesting the activation of
the endothelin signaling pathway. Production of inflammatory cytokines, IL-1β, TNFα, and
IL-6, was significantly enhanced by exogenous ET-1 treatment, and this effect depended on
the mitogen-activated protein kinases via intracellular Ca2+ increase, which resulted from
the activation of the phospholipase C/inositol 1,4,5-trisphosphate pathway. The inhibition of
the endothelin receptor-mediated signaling pathway with the dual receptor inhibitor, bosen-
tan, partially ameliorated alveolar bone loss and immune cell infiltration. These results
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suggest that endothelin plays an important role in P. gingivalis-mediated periodontitis. Thus,
endothelin antagonism may be a potential therapeutic approach for periodontitis treatment.
Introduction
The endothelin (ET) system comprises three 21-amino acid peptides (ET-1, -2, and -3), two G
protein-coupled receptors (ETA and ETB), and activating peptidases, including endothelin
converting enzymes (ECE-1 and -2). Endothelin, particularly ET-1, is implicated in many
pathological states of diseases and is associated with the progress of chronic inflammation in a
wide variety of organs through its ability to stimulate the production of inflammatory cyto-
kines [1, 2].
Periodontitis is a chronic inflammatory disease of the periodontium, which leads to the
destruction of both soft tissues and alveolar bone and the eventual exfoliation of the teeth.
Porphyromonas gingivalis in subgingival pockets is a major etiologic pathogen for periodon-
titis acting through the stimulation of host cells to produce inflammatory cytokines, includ-
ing interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor (TNF) α[3]. Several studies
have reported the potential involvement of ET-1 in periodontitis. Chen et al. suggested that
endothelin expression is significantly increased in the gingiva of chronic periodontitis com-
pared with the healthy one [4]. ET-1 peptide levels in gingival crevicular fluid and ET-1
mRNA expression in periodontal tissues from patients with periodontitis are higher than
those from healthy subjects [5, 6]. Genotype analysis suggests that the interaction of the
ET-1 gene with TNFβ and angiotensin-converting enzyme (ACE) may be involved in sus-
ceptibility to adult periodontitis [7]. Human gingival keratinocytes (HGKs) express
endothelin mRNAs, and IL-1β and TNFα enhance ET-1 peptide production [5]. Con-
versely, ET-1 induces IL-1β expression in KB cells and HPdLF cells [8]. Recently, Liang
et al. reported that ET-1 regulates pro-inflammatory cytokine production via the mitogen-
activated protein kinase (MAPK) pathway in human periodontal ligament cells (HPDLs)
[9]. In addition, ET-1 expression is strongly induced by P. gingivalis in KB cells and HEp-2
cells [6, 10].
The aforementioned findings imply the potential significance of endothelin in P. gingivalis
infection and in subsequent inflammatory responses that lead to periodontitis. However, most
of the studies discussed have been conducted with the epidermoid carcinoma cell line, KB, and
the larynx carcinoma cell line, HEp-2 [6, 8, 10]. Unfortunately, these cell lines are contami-
nated with the cervical adenocarcinoma cell line, HeLa [11, 12]. Thus, it is necessary to verify
the results of previous studies using physiological models such as primary human gingival epi-
thelial cells (HGECs). Moreover, the functional role of P. gingivalis-induced endothelin and
underlying mechanism of endothelin-mediated inflammatory cytokine production are still
unclear. The effects of endothelin antagonism on the development and progression of peri-
odontitis are also yet to be explored.
Therefore, in this study, we investigated the regulatory mechanisms of endothelin in P. gin-
givalis-mediated inflammatory response in HGECs. We further examined the effects of
endothelin receptor inhibitors on alveolar bone loss and inflammation in an animal model of
periodontitis.
Endothelin and Cytokine Production in Periodontitis
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Materials and Methods
Reagents
Keratinocyte Basal Medium-2 (KBM-2) was purchased from Lonza (Walkersville, MD, USA).
Collagenase A and Dispase II were obtained from Roche (Mannheim, Germany). P. gingivalis,
P. gingivalis LPS, P. gingivalis LPS-ulp, HKLM and Pam3 were purchased from Invivogen (San
Diego, CA, USA). BQ123 and BQ788 were obtained from American Peptides Company (Sun-
nyvale, CA, USA). Bosentan was a product of MedChem Express (Monmouth Junction, NJ,
USA). U73122, U73433, PD98059, SP600125, SB203580, 2-aminoethoxydiphenyl borate
(2-APB), 1,2-Bis(2-aminophenoxy)ethane-N, N, N’, N’-tetraacetic acid tetrakis(acetoxymethyl
ester) (BAPTA-AM) and Escherichia coli LPS were products of Sigma-Aldrich (St. Louis, MO,
USA).
Primary human gingival epithelial cells (HGECs) culture
HGECs were isolated from the gingival epithelium tissues resected during the extraction of
healthy donor’s wisdom teeth as described previously [13]. In brief, the gingival tissues were
separated from connective tissues after treatment with Collagenase A and Dispase II followed
by Trypsin/EDTA. The isolated single-cell suspensions were maintained in KBM-2. HGECs
within 3–4 passages were used for all experiments. All experimental protocol were reviewed
and approved by the Research Ethics Committee of Yonsei University College of Dentistry
and Dental Hospital. The written informed consent was obtained from all volunteers accord-
ing to the requirements of the Institutional Review Board.
Western blot analysis
Total proteins were extracted from the HGECs with radioimmunoprecipitation assay (RIPA)
buffer (BioSolution Inc., Suwon, Korea) containing protease inhibitor cocktails (Roche Diag-
nostics, Risch-Rotkreuz, Switzerland). Total protein samples were run on the polyacrylamide
gels using Mini-PROTEAN Tetra Cell Systems1 and then transferred to PVDF membranes in
Mini Trans-Blot cell (BIO-RAD, Hercules, CA, USA). The membranes were incubated with
antibodies against ETA, ETB, β-actin (Abcam, Cambridge, MA, USA), p-ERK, p-JNK, and p-
p38 (Cell Signaling Technology, Danvers, MA, USA). The blots were labeled with horseradish
peroxidase conjugated secondary antibody (Cell Signaling Technology). Specific complexes
were visualized with an enhanced chemiluminescence (ECL) detection system (GE Healthcare,
Little Chalfont, UK)
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from HGECs using the Trizol reagent (Invitrogen, Waltham, MA,
USA), and then cDNA synthesis was performed using AccuPower1 RT PreMix (BIONEER,
Daejeon, Korea) for conventional PCR and Superscript III (Invitrogen) for quantitative PCR.
For conventional PCR, cDNAs were amplified with EmeraldAmp GT PCR master mix (Takara
Bio Inc., Shiga, Japan) and the products were visualized on a 1.5% agarose gels. SensiFAST
SYBR Hi-ROX Kit (Bioline, Taunton, MA, USA) was used for quantitative PCR. The
sequences of primers used are listed in S1 Table.
Inflammatory cytokine measurement
Amount of secreted inflammatory cytokines was measured with supernatant from HGECs
using Qunatikine enzyme-linked immunosorbent assay (ELISA) kit for human IL-1β, TNFα
Endothelin and Cytokine Production in Periodontitis
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and IL-6 (Minneapolis, MN, USA). The epithelialcell viability was >90% and the value were
normalized with cell number.
P. gingivalis infection
P. gingivalis 33277 were grown anaerobically (85% N2, 10% H2, and 5% CO2) in brain heart
infusion medium with hemin and vitamin K. The bacteria, at multiplicities of infection (MOI)
of 100, were incubated with HGECs in antibiotic-free HGECs culture medium. After washing
with phosphate-buffered saline, the remaining external bacteria were killed with metronida-
zole and gentamicin. No effects of P. gingivalis (100 MOI) infection on the viability and growth
of cells were presented in Supporting Information (S1 Fig). P. gingivalis LPS standard (Pg LPS)
is produced by a standard LPS preparation. It exhibits TLR2 activity due to a contaminant
lipoprotein and also activates cells through TLR4 [14–16]. P. gingivalis LPS ultrapure (Pg LPS-
ulp) underwent enzymatic treatment to remove lipoproteins and thus only activates TLR4.
Endotoxin-free water utilized to dissolve both Pg LPS and Pg LPS was used as the solvent con-
trol in all the experiments.
Cell viability and proliferation assay
After P. gingivalis infection, apoptotic death was examined by staining cells with an Annexin
V-fluorescein isothiocyanate (FITC)/7-amino-actinomycin D (7-AAD) (BD Biosciences, San
Diego, CA, USA) as described by the manufacturer and analyzing with LSR II (BD Biosci-
ences). Both early (Annexin V-positive/7-AAD-negative) and late (Annexin V-positive/
7-AAD-positive) apoptotic cells were included in cell death determinations. Cell proliferation
was determined by adding MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium)-based CellTiter 96 AQueous One Solution Reagent (Pro-
mega, Madison, WI, USA) and measuring the absorbance at 490 nm on SPECTRA MAX 190
plate reader (Molecular Devices, Sunnyvale, CA, USA).
Measurement of intracellular Ca2+ concentration ([Ca2+]i)
Cultured HGECs on collagen-coated cover glasses were loaded with Fura-2/AM. Changes in
[Ca2+]i were measured by means of fura-2 fluorescence with excitation wavelengths of 340 and
380 nm, respectively, and an emission wavelength of 510 nm. The emitted fluorescence was
obtained at 2 s intervals and analyzed with a MetaFluor system (Molecular Devices).
Experimental design of animal study
After 1-week acclimation, 6-week old male C57BL/6 mice (Orient-Bio Inc., Seongnam, Korea)
were divided into the following four groups: control with vehicle (Con+Veh), control with
bosentan (Con+Bos), periodontitis with vehicle (Perio+Veh), and periodontitis with bosentan
(Perio+Bos) (n = 6 to 10 in each group at each time point). For ligature-induced periodontitis,
the mice were anesthetized intraperitoneally with a 1:2 mixture of Zoletil1 (30 mg/kg; Virbac,
Carros, France) and Rompun1 (10 mg/kg; Bayer Korea, Ansan, Korea). Dental floss was
placed around the cervix of the bilateral first molar and knotted mesially to induce periodonti-
tis [17]. Bosentan was prepared fresh every day as a suspension in 5% gum arabic (Sigma-
Aldrich). Vehicle (5% gum arabic) and bosentan (30 mg/kg) administrated daily via gastric
gavage. On day 3 or 9 after ligature, mice were sacrificed by CO2 inhalation and the mandibles
were dissected and analyzed histologically. During the experimental period, the location of
dental floss and gross appearance of mice were observed daily. Animal protocols were
Endothelin and Cytokine Production in Periodontitis
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approved by the Institutional Animal Care and Use Committee of the Yonsei University
Health System (2015–0146).
Histologic examination
The dissected mandibles were fixed in 10% neutral buffered formalin overnight and decalcified
in 5% nitric acid for 1 week. The paraffin-embedded sections were selected on clear appear-
ance of the dental pulp of the mesial and distal roots of the first molars and were stained with
hematoxylin and eosin [17]. For estimation of alveolar bone loss, the distance from the alveolar
bone crest (ABC) to the cementoenamel junction (CEJ) in the distal area and the percentage of
periodontal ligament area to the region of interest (ROI) in the furcation area were evaluated
under ×100 magnification (Olympus CKX41, Tokyo, Japan) and ImagePro software (Media
Cybernetics, Silver Spring, MD, USA). The height of the ROI was 0.8 mm from the top of the
furcation. For evaluation of inflammation, the number of polymorphonuclear and mononu-
clear cells were counted in two standardized sites (0.1 × 0.1 mm) located under the junctional
epithelium of the distal area of the first molar (×400 magnification). The evaluation was con-
ducted by an independent examiner in a blind manner.
Statistical analyses
Values are presented as the mean ± standard error of mean (SEM) based on results obtained
from at least three independent experiments. All statistical analyses were carried out using
GraphPad PRISM Software. Two-tailed unpaired Student’s t-test was used for comparisons
between two groups. One-way analysis of variance (ANOVA) followed by Tukey post hoc test
was used to identify any significant differences of the distance from CEJ to ABC, and the num-
ber of inflammatory cells after bosentan treatment. A P value of<0.05 was regarded as statisti-
cally significant.
Results
P. gingivalis induces ET-1 production in HGECs
To determine the role of endothelin in HGECs, we first examined the expression of ET-1 and
its receptors, ETA and ETB. ET-1 was expressed in all examined 25 samples and ETA was domi-
nantly present in HGECs (Fig 1A and 1B and S2 Fig). Next, we investigated the effect of P. gin-
givalis on the levels of ET-1 and ETA. Both P. gingivalis and P. gingivalis LPS (Pg LPS) up-
regulated the expression of ET-1 and ETA, indicating the activation of the ET-1/ETA signaling
pathway by P. gingivalis (Fig 1C and 1D and S3 Fig). Although Pg LPS is recognized predomi-
nantly by TLR4 [18], it also activates TLR2 due to a lipoprotein contaminant [16]. To examine
whether TLR activation is involved in P. gingivalis-mediated ET-1 production, we treated
HGECs with TLR2 agonists (HKLM and Pam3) or a TLR4 agonist (Pg LPS-ulp and E. coli
LPS). As shown in Fig 1E and 1F, ET-1 was significantly increased by the agonists of TLR2 and
TLR4 implying the involvement of TLR activation for the ET-1 production.
ET-1 mediates P. gingivalis-induced production of inflammatory
cytokines
To determine the role of ET-1 which is induced by P. gingivalis infection, we assessed the pro-
duction of inflammatory cytokines after treatment with inhibitors of endothelin receptors. P.
gingivalis induces the production of IL-1β, TNFα, and IL-6, and this induction was signifi-
cantly reduced by BQ123, an ETA blocker. In agreement with our results showing negligible
expression of ETB in HGECs (Fig 1B), inhibition of ETB by BQ788 had no effect on the
Endothelin and Cytokine Production in Periodontitis
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Fig 1. Endothelin expression in human gingival epithelial cells (HGECs) following P. gingivalis infection. (A and B) Expression
of ET-1 mRNA (A), and ETA and ETB protein (B) in HGECs was analyzed by RT-PCR and western blot, respectively. (C and D)
Induction of ET-1 peptide and ETA protein by P. gingivalis and P. gingivalis LPS. After 18h infection with P. gingivalis (100 MOI) and
24h treatment with P. gingivalis LPS (1 μg/ml), ET-1 peptide and ETA protein levels were analyzed by ELISA and western blot,
respectively. ET-1 levels were measured in culture supernatants from five samples (sample #1–5). A representative blot from sample
#1 is shown. *P<0.05; **P<0.01. (E and F) Involvement of TLR in ET-1 production. After 24h treatment with HKLM (108 cells/ml), or
Pam3 (50 ng/ml) (E), or Pg LPS-ulp (1 μg/ml) or E. coli LPS (50 ng/ml) (F), ET-1 production was evaluated by ELISA in culture
supernatants from five samples (sample #1–5). *P<0.05; **P<0.01.
doi:10.1371/journal.pone.0167713.g001
Endothelin and Cytokine Production in Periodontitis
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production of inflammatory cytokines. Bosentan, a dual inhibitor of ETA and ETB prevented
the secretion of inflammatory cytokines, which could be the result of ETA inhibition (Fig 2A to
2C). Pg LPS also induced the production of IL-1β, TNFα, and IL-6, and this was attenuated by
treatment with BQ123 or bosentan, but not with BQ788 (Fig 2D to 2F). Next, we examined
whether the ETA signaling pathway, activated by ET-1, directly affects the production of
inflammatory cytokines in HGECs. As shown in Fig 2G to 2I, ET-1 directly induced the secre-
tion of IL-1β, TNFα, and IL-6 in HGECs, and inhibition of ETA with BQ123 or bosentan
resulted in a reversal of the influence of ET-1 on cytokine production.
ET-1 stimulates the production of inflammatory cytokines via
Ca2+-activated signaling pathway
Because ETA is a Gq protein-coupled receptor, we examined whether the phospholipase C/ino-
sitol 1, 4, 5-trisphosphate (PLC/IP3)-mediated intracellular Ca
2+ concentration ([Ca2+]i)
increase is involved in the production of inflammatory cytokines. ET-1 stimulated the increase
in [Ca2+]i in HGECs, and this was prevented by the ETA receptor blockers, BQ123 and bosen-
tan (Fig 3A and 3B). To directly examine whether the increase in [Ca2+]i can influence the
secretion of inflammatory cytokines, we exposed HGECs to ET-1, along with the intracellular
Ca2+-selective chelator, BAPTA-AM. The ET-1-induced secretion of inflammatory cytokines
was markedly repressed by BAPTA-AM (Fig 3C to 3E). In addition, to determine the role of
the PLC/IP3 pathway in ET-1-induced inflammatory cytokine production, we treated HGECs
with U73122, a specific inhibitor of PLC, or its inactive analog, U73343, and the IP3 receptor
blocker, 2-APB. As shown in Fig 3F to 3H, U73122, but not U73343, suppressed ET-1-induced
production of inflammatory cytokines. 2-APB also inhibited cytokine expression. Because
MAPKs, which have been shown to be involved in ET-1-mediated inflammatory cytokine pro-
duction in HPDLs, are influenced by Ca2+ signaling [9, 19], we explored the involvement of
MAPKs in HGECs. As shown in S4 Fig, JNK and ERK1/2 but not p38 were activated by Pg, Pg
LPS and ET-1. In addition, induction of IL-1β, TNFα, and IL-6 by ET-1 was significantly
blocked by inhibition of JNK (SP600125) and ERK1/2 (PD98059) but inhibition of p38
(SB203580) had little effect on ET-1-induced mRNA (Fig 4A to 4C) and protein (Fig 4D to 4F)
expression of cytokine.
Inhibition of endothelin signaling partially ameliorates the progression of
periodontitis
Bosentan prevented the secretion of inflammatory cytokines (Fig 2G to 2I). Thus, we evaluated
the beneficial effects of bosentan on the mice with ligature-induced periodontitis (Fig 5A).
Morphometric analysis demonstrated that the distance from the cementoenamel junction
(CEJ) to the alveolar bone crest (ABC) in the control group treated with vehicle was shorter
than that in the periodontitis group throughout the experimental period. In the periodontitis
group, at early time point, the mice that received bosentan exhibited less severe bone loss than
those that received vehicle (day 3; CEJ-ABC distance of 0.30 ± 0.02 mm and 0.22 ± 0.01 mm,
respectively). Despite the statistical insignificance, the mice that received bosentan tended to
display less severe bone loss at later time point than those that received vehicle (day 9; Fig 5B).
In accordance with the morphometric results, the histological images revealed that the bone
crest and junctional epithelium remained normal in the control group. However, in the peri-
odontitis group, alveolar bone resorption was extensive, and the junctional epithelium was
elongated. These effects were reduced in the bosentan treatment (Fig 5C). As illustrated in Fig
5D, an increased number of inflammatory cells was detected in the periodontitis group
Endothelin and Cytokine Production in Periodontitis
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Fig 2. Effect of endothelin inhibitors on the production of inflammatory cytokines in HGECs. (A to C) Reduced production of IL-1β
(A), TNFα (B), and IL-6 (C) after treatment with endothelin receptor antagonists and P. gingivalis. After treatment with BQ123 (100 nM),
BQ788 (100 nM), or bosentan (100 nM) for 1h, cells were infected with P. gingivalis (100 MOI) for 24h. (D to F) Reduced production of IL-1β
(D), TNFα (E), and IL-6 (F) after treatment with endothelin receptor antagonists and P. gingivalis LPS (1 μg/ml). After treatment with BQ123
(100 nM), BQ788 (100 nM), or bosentan (100 nM) for 1h, cells were treated with P. gingivalis LPS (1 μg/ml) for 24h. (G to I) Reduced
production of IL-1β (G), TNFα (H), and IL-6 (I) after treatment with endothelin receptor antagonists and ET-1. After pre-treatment with
BQ123 (100 nM), BQ788 (100 nM), and bosentan (100 nM) for 1h, cells were treated with ET-1 (100 nM) for 24h. Secretion of cytokines or
ET-1 was examined by ELISA in the culture supernatants from five samples (sample #1–5). *P<0.05; **P<0.01; ***P<0.001.
doi:10.1371/journal.pone.0167713.g002
Endothelin and Cytokine Production in Periodontitis
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Fig 3. Involvement of the Ca2+/PLC/IP3 pathway in endothelin-mediated inflammatory cytokine production. (A and B) ET-1-induced
increase in intracellular Ca2+ concentration [Ca2+]i. The fura-2/AM- stained cells were treated with ET-1 and BQ123 (100 nM) (A) or
bosentan (100 nM) (B). Change of [Ca2+]i was measured through fluorescence intensity at excitation wavelengths of 340 and 380 nm. (C to
E) Effect of BAPTA-AM on ET-1-mediated production of inflammatory cytokines. After pre-treatment with BAPTA-AM (5 μM) for 20 min,
HGECs were treated with ET-1 (100 nM) for 24h and production of IL-1β (F), TNFα (G), and IL-6 (H) was measured by ELISA in culture
supernatants from five samples (sample #1–5). *P<0.05; **P<0.01. (F to H) Involvement of the PLC/IP3 pathway in the ET-1-induced
production of inflammatory cytokines. After pre-treatment with U73122 (10 μM), U73342 (10 μM), or 2-APB (75 μM) for 30 min, HGECs were
treated with ET-1 (100 nM) for 24h and production of IL-1β (C), TNFα (D), and IL-6 (E) was measured by ELISA in culture supernatants from
five samples (sample #1–5). *P<0.05; **P<0.01.
doi:10.1371/journal.pone.0167713.g003
Endothelin and Cytokine Production in Periodontitis
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compared with the control group. However, at later time point, bosentan treatment signifi-
cantly reduced the number of inflammatory cells (day 9; Fig 5D and 5E).
Discussion
P. gingivalis has been regarded as one of the major etiologic agents in chronic periodontitis.
Interestingly, it produces endopeptidase PgPepO, which has a significant homology with
endothelin-converting enzyme (ECE)-1 [20]. Although further investigation is needed, this
points to the possibility that the activation of PgPepO after P. gingivalis infection may contrib-
ute to ET-1 production in host cells. A previous report shows that a PgPepO-deficient strain
has a lower capability of invasion compared to wild type strains [21]. This implies that P. gingi-
valis may use endothelin for the bacterial invasion process. In addition, ET-1 may induce host
inflammation of periodontal tissues in response to P. gingivalis infection.
Fig 4. Involvement of MAPK in endothelin-mediated inflammatory cytokine production. (A to C) Effect of MAPK inhibitors on the ET-
1-mediated mRNA expression of inflammatory cytokines. After pre-treatment with PD98059 (10 μM), SP600125 (10 μM), and SB203580
(10 μM) for 20 min, HGECs were treated with ET-1 (100 nM) for 24h and mRNA expression of IL-1β (F), TNFα (G), and IL-6 (H) was
measured by quantitative RT-PCR. *P<0.05; **P<0.01; **P<0.001. (D to F) Effect of MAPK inhibitors on the ET-1-mediated production of
inflammatory cytokines. After pre-treatment with PD98059 (10 μM), SP600125 (10 μM) and SB203580 (10 μM) for 20 min, HGECs were
treated with ET-1 (100 nM) for 24h and production of IL-1β (F), TNFα (G), and IL-6 (H) was measured by ELISA in culture supernatants from
five samples (sample #1–5). *P<0.05; **P<0.01; ns: non-significant.
doi:10.1371/journal.pone.0167713.g004
Endothelin and Cytokine Production in Periodontitis
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Fig 5. Effect of endothelin inhibition on ligature-induced periodontitis. (A) Experimental design and time schedule. Ligature
was placed on day 0, and bosentan was treated 1 day before ligature ligation (-1 day). On days 3 and 9 after ligature ligation, the
mandibles were dissected and histomorphometric and immunohistochemical analyses were performed. (B and C) Effect of
endothelin inhibition on alveolar bone loss on days 3 and 9. ABC-CEJ distances measured by histomorphometric analysis (B) are
shown along with representative image (C). *P<0.05; ***P<0.001; ns: non-significant. (D and E) Effect of endothelin inhibition on
the number of inflammatory cells in the gingiva on days 3 and 9. Number of inflammatory cells (D) measured by
immunohistochemical analysis are shown along with the representative image (E). **P<0.01; ***P<0.001. Scale bar = 100 μm;
original magnification ×20.
doi:10.1371/journal.pone.0167713.g005
Endothelin and Cytokine Production in Periodontitis
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ET-1 is induced by P. gingivalis in KB and HEp-2 cell lines, which were unfortunately con-
taminated with HeLa cells [11, 12], but little information has been revealed on the underlying
molecular mechanism. Therefore, ET-1 induction should be verified and the underlying mech-
anisms need to be revealed in an appropriate system reflecting oral environment. In this study,
we found the expression of ET-1 and ETA in HGECs and both TLR2 and TLR4 are involved in
P. gingivalis-mediated ET-1 production. It would be of interest to examine whether PgPepO,
through ET-1 production, evokes an immune response via the TLR signaling pathway in
HGECs as has been shown in immune system activation that results from the interaction of
Streptococcus pneumonia endopeptidase O with TLRs [22].
Endothelin signaling has been shown to directly activate the immune response and the infil-
tration of immune cells into the site of inflammation [23]. P. gingivalis up-regulates the expres-
sion of ET-1 along with IL-1β, IL-8, and intercellular adhesion molecule (ICAM-1), in HEp-2
cells [6]. Rikimaru et al. showed that ET-1 stimulates IL-1β production in KB and PDL cells
[8]. Because the progression of periodontitis is closely related with the expression of inflamma-
tory cytokines such as IL-1β, -6, -8 and TNFα in gingival tissues [24, 25], ET-1 could play
important roles in the initiation and progression of the disease through the regulation of cyto-
kine expression. The signaling pathways involved in ET-1-mediated cytokine production via
MAPKs have been investigated in HPDLs [9]. Our study indicates that ET-1 activates ERK1/2
and JNK, but not p38 in HGECs (Fig 4). Additionally, we report the novel finding that the
PLC/IP3 pathway-mediated increase in [Ca
2+]i plays a critical role in ET-1 function. For these
experiments, we have used chemical inhibitors to determine the ET-1-mediated signal trans-
duction. However, genetic knockdown approaches using si- or shRNAs will be required to
exclude the potential off-target effects of the chemicals and to entirely confirm the conclusions.
Several inflammatory cytokines, such as IL-1β, -6, and -8, are known to up-regulate ET-1 pro-
duction [26]. Moreover, Fujioka et al. showed that ET-1 mRNA expression and peptide pro-
duction are increased by IL-1β and TNFα in human gingival keratinocytes [5]. Thus, the
reciprocal interaction between ET-1 and inflammatory cytokines may contribute to the long-
term progression of periodontitis after P. gingivalis infection. ET-1 and inflammatory cyto-
kines may be interdependent and may establish an inflammatory loop, which can contribute
to the incidence and progression of chronic periodontitis.
Activation of inflammatory cytokines results in alveolar bone loss by inducing osteoclast
formation [27]. It has been suggested that ET-1 is involved in orthodontic tooth movement
probably by enhancing bone resorption [28]. In addition to an indirect participation in peri-
odontitis via the induction of inflammatory cytokines, ET-1 may directly aggravate the disease
through the enhancement of osteoclast formation, eventually leading to alveolar bone loss.
Inhibitors of endothelin receptors prevent the development of inflammation-related diseases
such as colitis, airway inflammation, and collagen-induced arthritis [29–31]. In our study,
bosentan alleviates alveolar bone loss and infiltration of inflammatory cells in an animal model
of ligature-induced periodontitis (Fig 5). However, bosentan was not fully effective during the
entire experimental period. Bosentan treatment was statistically potent only at the early stages
of alveolar bone loss during the course of the disease, and its effect was diminished at later time
points (Fig 5B). In periodontitis, receptor activator of nuclear factor-kB ligand (RANKL) is a
critical factor for alveolar bone loss along with pro-inflammatory cytokines [32, 33]. Interest-
ingly, ET-1 did not affect RANKL secretion in HGECs (S5 Fig). Thus, it is likely that bosentan
was able to prevent pro-inflammatory cytokine-mediated bone loss at earlier time point but
was unable to inhibit RANKL-induced bone destruction later. It would be interesting to know
whether the secretion of pro-inflammatory cytokines and of RNAKL occurs sequentially. Our
results suggest that long-term treatment of bosentan or co-treatment with a RANKL inhibitor
such as osteoprotegerin (OPG), might be more effective for the prevention of bone loss.
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In the present study, we reported that the induction of ET-1 and ETA by P. gingivalis plays
an important role in the production of inflammatory cytokines in HGECs. In addition, we
demonstrated that MAPK activation via the increase in intracellular Ca2+ that results from the
activation of the PLC/IP3 is the underlying mechanism of ET-1 action. Finally, we showed that
inhibition of ET-1/ETA with bosentan partially ameliorated alveolar bone loss and immune
cell infiltration suggesting the potential therapeutic approach of endothelin antagonism for
periodontitis.
Supporting Information
S1 Table. List of primer sequences used in the study.
(TIF)
S1 Fig. No effect of P. gingivalis infection on the viability and growth of HGECs. (A and B)
After 18h infection with P. gingivalis (100 MOI) apoptotic cell death was determined by flow
cytometric analysis using double staining with Annexin V-FITC and 7-AAD (A) and cell
growth was examined by MTS assay (B).
(PPTX)
S2 Fig. Additional analysis of endothelin expression in HGECs. RNA was extracted from
human gingival epithelial cells and mRNA expression of ET-1, ETA and ETB in HGECs was
analyzed by RT-PCR. GAPDH was used as loading control.
(PPTX)
S3 Fig. Induction of mRNAs of ET-1 and ETA by Pg or Pg LPS. ET-1 (A and B) or ETA (C
and D) mRNA expression was examined by quantitative RT-PCR after Pg (100 MOI; A and C)
infection for 18h or Pg LPS (1 μg/ml; B and D) treatment for 24h. P<0.05; P<0.01;
P<0.001.
(PPTX)
S4 Fig. Activation of MAPKs by Pg, Pg LPS or ET-1. Phosphorylation of JNK, ERK and p38
was examined by Western blot with phosphorylation-specific antibodies. β-actin was used as a
loading control.
(PPTX)
S5 Fig. No effect of ET-1 on the production of RANKL and OPG in HGECs. (A and B) ET-
1 (100 nM) was treated at the indicated times, and the secretion of RANKL (A) and OPG (B)
was examined by ELISA in culture supernatants from five samples (sample #1–5).
(PPTX)
Author Contributions
Conceptualization: IC DMS.
Data curation: GYS EJB IC.
Formal analysis: IC EJB JHK DEL.
Funding acquisition: IC DMS.
Investigation: GYS JHK DEL SMK SYL LC JSS SKK.
Methodology: IC EJB.
Project administration: IC DMS.
Endothelin and Cytokine Production in Periodontitis
PLOS ONE | DOI:10.1371/journal.pone.0167713 December 28, 2016 13 / 15
Resources: SMK WP BIK YJY.
Supervision: IC DMS.
Validation: GYS SYL.
Visualization: IC EJB.
Writing – original draft: IC DMS.
Writing – review & editing: IC DMS.
References
1. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease.
Annu Rev Pharmacol Toxicol. 2001; 41:851–76. doi: 10.1146/annurev.pharmtox.41.1.851 PMID:
11264479
2. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology,
and pathophysiology. Pharmacol Rev. 1994; 46(3):325–415. PMID: 7831383
3. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010; 8
(7):481–90. doi: 10.1038/nrmicro2337 PMID: 20514045
4. Chen S, Wu J, Song Z, Zhang J. An investigation of immunocompetence substances in normal gingival
and periodontitis tissue. Chin Med J (Engl). 2000; 113(9):844–7.
5. Fujioka D, Nakamura S, Yoshino H, Shinohara H, Shiba H, Mizuno N, et al. Expression of endothelins
and their receptors in cells from human periodontal tissues. J Periodontal Res. 2003; 38(3):269–75.
PMID: 12753364
6. Ansai T, Yamamoto E, Awano S, Yu W, Turner AJ, Takehara T. Effects of periodontopathic bacteria on
the expression of endothelin-1 in gingival epithelial cells in adult periodontitis. Clin Sci (Lond). 2002; 103
Suppl 48:327S–31S.
7. Holla LI, Fassmann A, Vasku A, Znojil V, Vanek J, Vacha J. Interactions of lymphotoxin alpha (TNF-
beta), angiotensin-converting enzyme (ACE), and endothelin-1 (ET-1) gene polymorphisms in adult
periodontitis. J Periodontol. 2001; 72(1):85–9. doi: 10.1902/jop.2001.72.1.85 PMID: 11210078
8. Rikimaru T, Awano S, Mineoka T, Yoshida A, Ansai T, Takehara T. Relationship between endothelin-1
and interleukin-1beta in inflamed periodontal tissues. Biomed Res. 2009; 30(6):349–55. PMID:
20051644
9. Liang L, Yu J, Zhou W, Liu N, E LL, Wang DS, et al. Endothelin-1 stimulates proinflammatory cytokine
expression in human periodontal ligament cells via mitogen-activated protein kinase pathway. J Period-
ontol. 2014; 85(4):618–26. doi: 10.1902/jop.2013.130195 PMID: 23701479
10. Yamamoto E, Awano S, Koseki T, Ansai T, Takehara T. Expression of endothelin-1 in gingival epithelial
cells. J Periodontal Res. 2003; 38(4):417–21. PMID: 12828660
11. Lacroix M. Persistent use of "false" cell lines. Int J Cancer. 2008; 122(1):1–4. doi: 10.1002/ijc.23233
PMID: 17960586
12. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002; 2(4):315–9.
doi: 10.1038/nrc775 PMID: 12001993
13. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of
gingival epithelial cells. Infect Immun. 1995; 63(10):3878–85. PMID: 7558295
14. Kirikae T, Nitta T, Kirikae F, Suda Y, Kusumoto S, Qureshi N, et al. Lipopolysaccharides (LPS) of oral
black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macro-
phages in a way different from that of Salmonella LPS. Infect Immun. 1999; 67(4):1736–42. PMID:
10085012
15. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, et al. Signaling by toll-like
receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun.
2001; 69(3):1477–82. doi: 10.1128/IAI.69.3.1477-1482.2001 PMID: 11179315
16. Ogawa T, Asai Y, Makimura Y, Tamai R. Chemical structure and immunobiological activity of Porphyro-
monas gingivalis lipid A. Front Biosci. 2007; 12:3795–812. PMID: 17485340
17. Kim JH, Lee DE, Choi SH, Cha JH, Bak EJ, Yoo YJ. Diabetic characteristics and alveolar bone loss in
streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis. J Periodontal Res. 2014;
49(6):792–800. doi: 10.1111/jre.12165 PMID: 24490978
Endothelin and Cytokine Production in Periodontitis
PLOS ONE | DOI:10.1371/journal.pone.0167713 December 28, 2016 14 / 15
18. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ
and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282(5396):2085–8. PMID: 9851930
19. Agell N, Bachs O, Rocamora N, Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+),
and calmodulin. Cell Signal. 2002; 14(8):649–54. PMID: 12020764
20. Awano S, Ansai T, Mochizuki H, Yu W, Tanzawa K, Turner AJ, et al. Sequencing, expression and bio-
chemical characterization of the Porphyromonas gingivalis pepO gene encoding a protein homologous
to human endothelin-converting enzyme. FEBS Lett. 1999; 460(1):139–44. PMID: 10571076
21. Ansai T, Yu W, Urnowey S, Barik S, Takehara T. Construction of a pepO gene-deficient mutant of Por-
phyromonas gingivalis: potential role of endopeptidase O in the invasion of host cells. Oral Microbiol
Immunol. 2003; 18(6):398–400. PMID: 14622347
22. Zhang H, Kang L, Yao H, He Y, Wang X, Xu W, et al. Streptococcus pneumoniae Endopeptidase O
(PepO) Elicits a Strong Innate Immune Response in Mice via TLR2 and TLR4 Signaling Pathways.
Front Cell Infect Microbiol. 2016; 6:23. doi: 10.3389/fcimb.2016.00023 PMID: 26973817
23. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease.
Cardiovasc Res. 2007; 76(1):8–18. doi: 10.1016/j.cardiores.2007.06.004 PMID: 17617392
24. Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J
Periodontol. 1996; 67(5):515–22. doi: 10.1902/jop.1996.67.5.515 PMID: 8724710
25. Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K. Cytokine messenger RNA
expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol. 1997; 12(5):281–7.
PMID: 9467381
26. Nakano J, Takizawa H, Ohtoshi T, Shoji S, Yamaguchi M, Ishii A, et al. Endotoxin and pro-inflammatory
cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin Exp Allergy.
1994; 24(4):330–6. PMID: 8039018
27. Souza PP, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol Invest. 2013; 42
(7):555–622. doi: 10.3109/08820139.2013.822766 PMID: 24004059
28. Sprogar S, Vaupotic T, Cor A, Drevensek M, Drevensek G. The endothelin system mediates bone
modeling in the late stage of orthodontic tooth movement in rats. Bone. 2008; 43(4):740–7. doi: 10.
1016/j.bone.2008.06.012 PMID: 18656564
29. Anthoni C, Mennigen RB, Rijcken EJ, Laukotter MG, Spiegel HU, Senninger N, et al. Bosentan, an
endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of
inflammatory bowel disease. Int J Colorectal Dis. 2006; 21(5):409–18. doi: 10.1007/s00384-005-0015-3
PMID: 16088386
30. Finsnes F, Skjonsberg OH, Tonnessen T, Naess O, Lyberg T, Christensen G. Endothelin production
and effects of endothelin antagonism during experimental airway inflammation. Am J Respir Crit Care
Med. 1997; 155(4):1404–12. doi: 10.1164/ajrccm.155.4.9105086 PMID: 9105086
31. Donate PB, Cunha TM, Verri WA Jr., Junta CM, Lima FO, Vieira SM, et al. Bosentan, an endothelin
receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-alpha in the induction of
endothelin system genes. Inflamm Res. 2012; 61(4):337–48. doi: 10.1007/s00011-011-0415-5 PMID:
22249931
32. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J
Dent Res. 2011; 90(2):143–53. doi: 10.1177/0022034510385236 PMID: 21135192
33. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008; 79(8
Suppl):1569–76. doi: 10.1902/jop.2008.080233 PMID: 18673012
Endothelin and Cytokine Production in Periodontitis
PLOS ONE | DOI:10.1371/journal.pone.0167713 December 28, 2016 15 / 15
